Sfoglia per Autore
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
2011 Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A.
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
2011 De Iaco P.; Musto A.; Orazi L.; Zamagni C.; Rosati M.; Allegri V.; Cacciari N.; Al-Nahhas A.; Rubello D.; Venturoli S.; Fanti S.
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance
2012 Guerra F.; Perrone A.M.; Kurelac I.; Santini D.; Ceccarelli C.; Cricca M.; Zamagni C.; De Iaco P.; Gasparre G.
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma.
2012 Stella F.; Dell'Amore A.; Dolci G.; Cassanelli N.; Caroli G.; Zamagni C.; Bini A.
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment
2012 Taffurelli M; Montroni I; Santini D; Zamagni C; Fiacchi M; Zanotti S; Pellegrini A; Ugolini G
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers
2014 Flora Guerra;Giulia Girolimetti;Anna Myriam Perrone;Martina Procaccini;Ivana Kurelac;Claudio Ceccarelli;Dario De Biase;Giacomo Caprara;Claudio Zamagni;Pierandrea De Iaco;Donatella Santini;Giuseppe Gasparre
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points.
2014 Perrone, Am; Zamagni, C; De Iaco, P
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs
2015 Diemberger, Igor; Massaro, Giulia; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Martignani, Cristian; Ziacchi, Matteo; Biffi, Mauro; Bernardi, Alessandra; Cacciari, Nicoletta; Zamagni, Claudio; Boriani, Giuseppe
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report
2017 Minichillo, Santino; Gallelli, Ilaria; Barbieri, Elena; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Dall'Olio, Massimo; Rapezzi, Claudio; Zamagni, Claudio
Liquid biopsy in the diagnosis of HPV DNA in breast lesions
2018 De Carolis, Sabrina; Pellegrini, Alice; Santini, Donatella; Ceccarelli, Claudio; De Leo, Antonio; Alessandrini, Federica; Arienti, Chiara; Pignatta, Sara; Tesei, Anna; Mantovani, Vilma; Zamagni, Claudio; Taffurelli, Mario; Sansone, Pasquale; Bonafé, Massimiliano; Cricca, Monica
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach
2018 Nannini, Margherita*; Dondi, Giulia; Santini, Donatella; De Leo, Antonio; Dei Tos, Angelo Paolo; Zamagni, Claudio; Saponara, Maristella; Gatto, Lidia; Nigro, Concetta; Bertaccini, Paola; Zompatori, Maurizio; De Iaco, Pierandrea; Perrone, Anna Myriam; Pantaleo, Maria Abbondanza
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm.
2019 G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zamagni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini.
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed
2019 Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
2019 Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.; Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F.
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer
2020 Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Rubner M.; Fasching P.A.; Wurfel W.; Zamagni C.
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results
2020 Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo
Radiotherapy in uterine sarcoma: a narrative review of international guidelines
2021 Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; Buwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification
2021 De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S.; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C.
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
2021 Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, Anna Myriam Perrone, Pierandrea De Iaco, Antonio De Leo
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak
2021 Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. | Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia ...S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A. | 2011-01-01 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. | De Iaco P.; Musto A.; Orazi L.; Zamagni C.; Rosati M.; Allegri V.; Cacciari N.; Al-Nahhas A.; Rub...ello D.; Venturoli S.; Fanti S. | 2011-01-01 | EUROPEAN JOURNAL OF RADIOLOGY | - | 1.01 Articolo in rivista | - |
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance | Guerra F.; Perrone A.M.; Kurelac I.; Santini D.; Ceccarelli C.; Cricca M.; Zamagni C.; De Iaco P....; Gasparre G. | 2012-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. | Stella F.; Dell'Amore A.; Dolci G.; Cassanelli N.; Caroli G.; Zamagni C.; Bini A. | 2012-01-01 | ANNALS OF THORACIC SURGERY | - | 1.01 Articolo in rivista | - |
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment | Taffurelli M; Montroni I; Santini D; Zamagni C; Fiacchi M; Zanotti S; Pellegrini A; Ugolini G | 2012-01-01 | THE BREAST | - | 1.01 Articolo in rivista | - |
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers | Flora Guerra;Giulia Girolimetti;Anna Myriam Perrone;Martina Procaccini;Ivana Kurelac;Claudio Cecc...arelli;Dario De Biase;Giacomo Caprara;Claudio Zamagni;Pierandrea De Iaco;Donatella Santini;Giuseppe Gasparre | 2014-01-01 | MODERN PATHOLOGY | - | 1.01 Articolo in rivista | - |
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. | Perrone, Am; Zamagni, C; De Iaco, P | 2014-01-01 | EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs | Diemberger, Igor; Massaro, Giulia; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Martignani, Cr...istian; Ziacchi, Matteo; Biffi, Mauro; Bernardi, Alessandra; Cacciari, Nicoletta; Zamagni, Claudio; Boriani, Giuseppe | 2015-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report | Minichillo, Santino; Gallelli, Ilaria; Barbieri, Elena; Cubelli, Marta; Rubino, Daniela; Quercia,... Sara; Dall'Olio, Massimo; Rapezzi, Claudio; Zamagni, Claudio | 2017-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 12885_2017_Article_3712.pdf |
Liquid biopsy in the diagnosis of HPV DNA in breast lesions | De Carolis, Sabrina; Pellegrini, Alice; Santini, Donatella; Ceccarelli, Claudio; De Leo, Antonio;... Alessandrini, Federica; Arienti, Chiara; Pignatta, Sara; Tesei, Anna; Mantovani, Vilma; Zamagni, Claudio; Taffurelli, Mario; Sansone, Pasquale; Bonafé, Massimiliano; Cricca, Monica | 2018-01-01 | FUTURE MICROBIOLOGY | - | 1.01 Articolo in rivista | - |
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach | Nannini, Margherita*; Dondi, Giulia; Santini, Donatella; De Leo, Antonio; Dei Tos, Angelo Paolo; ...Zamagni, Claudio; Saponara, Maristella; Gatto, Lidia; Nigro, Concetta; Bertaccini, Paola; Zompatori, Maurizio; De Iaco, Pierandrea; Perrone, Anna Myriam; Pantaleo, Maria Abbondanza | 2018-01-01 | CLINICAL MEDICINE INSIGHTS: ONCOLOGY | - | 1.01 Articolo in rivista | A Single-Centre Experience on the Management of Adenosarcoma.pdf |
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. | G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zama...gni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini. | 2019-01-01 | PATHOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed | Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D. | 2019-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | PlosONE Ceccarelli et al. journal.pone.0217937-1.pdf |
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial | Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.;... Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F. | 2019-01-01 | BMC MEDICINE | - | 1.01 Articolo in rivista | HER2 2019.pdf |
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer | Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Ru...bner M.; Fasching P.A.; Wurfel W.; Zamagni C. | 2020-01-01 | GEBURTSHILFE UND FRAUENHEILKUNDE | - | 1.01 Articolo in rivista | a-1128-6664(1).pdf |
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results | Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; ...Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo | 2020-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cortesi_et_al-2020-Cancer_Medicine.pdf |
Radiotherapy in uterine sarcoma: a narrative review of international guidelines | Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; B...uwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia | 2021-01-01 | GYNECOLOGY AND PELVIC MEDICINE | - | 1.01 Articolo in rivista | - |
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification | De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S....; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | DeLeo2021cancers-13-00950.pdf |
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma | Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, An...na Myriam Perrone, Pierandrea De Iaco, Antonio De Leo | 2021-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak | Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo ...A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P. | 2021-01-01 | GYNECOLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile